Institutional investors purchased a net $1.4 million shares of TXMD during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 48.46% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
COPPER ROCK CAPITAL PARTNERS LLC Bought 127.6 Thousand shares of TherapeuticsMD Inc
OLD MUTUAL INVESTMENT MANAGEMENT... Bought 101.2 Thousand shares of TherapeuticsMD Inc
J. W. BURNS & CO., INC. (NEW YOR... Bought 41.4 Thousand shares of TherapeuticsMD Inc